In a significant reconfiguration of how the American government delivers care to its most vulnerable, federal health programs have begun entrusting artificial intelligence with the work of therapists and prescribers — roles long considered the province of human judgment and clinical relationship. The move, accelerated under the Trump administration as a remedy for clinician shortages and rising costs, has unsettled medical professionals who see a dangerous gap between the speed of deployment and the maturity of the science. At stake is not merely a question of technology, but of who bears resp